← Open Payments lookup

THOMAS SMURA: Open Payments

NPI 1417583998 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,021 in 54 payments from 13 companies in 2025. Trend: 2023 $615 · 2024 $1,419 · 2025 $1,021

Food & beverage: $1,021
CompanyPaymentsAmount
ABBVIE INC.12$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$182
Teva Pharmaceuticals USA, Inc.5$100
E.R. Squibb & Sons, L.L.C.4$89
Alkermes, Inc.4$83
Axsome Therapeutics, Inc.3$74
Takeda Pharmaceuticals U.S.A., Inc.3$72
Neurocrine BioSciences, Inc.3$58
Lundbeck LLC2$45
Vanda Pharmaceuticals Inc.2$39

Products named: VRAYLAR, CAPLYTA, UZEDY, COBENFY, ARISTADA, Auvelity, TRINTELLIX, INGREZZA.

Industry payments across FL — which companies pay providers there.